For the purposes of this review, several aspects need to be considered. First, the activation of T cells is somewhat different from the activation of other cells. T-cell activation is de~endent transduction can take several forms or be expressed on different cell types including the APC, the lymphokine-secreting cell, and the lymphokine-responsive cell. The defects may reside in expression of critical surface molecules or receptors or pivotal enzymes, genes, or their enhancing proteins. The synchrony of all these events is required for the initiation and continuance of cell cycle progression and the general increases in protein, lipid, and RNA synthesis.
APC
To effectively present antigen, APC generate immunogenic peptides from the more complex parent protein. These peptides may then be bound to an MHC class I1 molecule, and it is this complex on the surface of the APC that serves as the stimulatory ligand for the TCR. The generation of immunogenic peptides and intracellular trafficking of peptide-MHC is slowly being unraveled. A series of mutant APC has been generated with defects in antigen presentation in spite of normal class I1 expression ( 1, 2). Several patients have been described with defective expression of HLA class I and class I1 proteins (3-5). In general, these patients have near-normal mitogen-induced proliferative responses but absent antigen-specific responses.
A number of accessory molecules may play a role in efficient coupling of APC and antigen-specific T cells. These include CD28 on T cells and its ligand on APC, and a variety of adhesion molecules, including ICAM-1 and LFA-1. Defects in adhesion molecule expression have more commonly been associated with defective neutrophil function and not primarily with T-cell immunodeficiency (6).
LYMPHOKINE SYNTHESIS AND SECRETION
on cell-cell contact between an APC and the T cell. T& ligand Central to the T-cell proliferative response is the synthesis and for the TCR is the peptide-MHC complex presented by the APC. secretion of the IL. The majority of the work has focused on the Second, ligation of the TCR complex leads to expression of events that regulate induction of IL-2 synthesis. It is likely that lymphokine receptors and lymphokine secretion. This autocrine the production of IL-4 is similarly regulated. As with the majority pathway results in T-cell proliferation. Third, in consideration of activation genes, transcriptional regulation accounts for most of potential T-cell defects as a result of a signaling abnormality, of the levels of IL gene expression (7). Our data indicate that the we must also delineate whether only the T cells express a partic-increases in IL-2 gene transcription and synthesis/secretion are ular protein required for activation or whether all cells express critically dependent on increases in concentrations of (Ca2+)i (8).
this protein but only T cells are dependent on it for normal Increases in cytosolic Ca2+ may be achieved by release of Ca2+ function.
from sequestered stores, primarily the endoplasmic reticulum; For the most part, the defects considered are likely to be transmembrane uptake of Ca2+; and a decrease in Ca2+ extrusion genetic in nature, leading to the early onset of symptoms of T-by the Ca2+ pump. Transmembrane uptake of Ca2+ resulting in cell immunodeficiency. Acquired abnormalities of signal trans-sustained increases in (Ca2+)i appears to be the essential compoduction could result from viral infection (e.g. AIDS) or drugs nent: store release alone is insuficient. Calcium uptake across (e.g, the immunosuppressants cyclosporin A or FK506). Figure the T-cell plasma membrane is likely through ligand-gated but 1 illustrates one scheme for T-cell activation focusing on a not voltage-gated Ca2+ channels (9). number of presumed critical events. Abnormalities of signal
The stimulus for opening the plasma membrane Ca2+ channel (10). The former results in the liberation of Ca2+ from internal stores and the latter in the activation of protein kinase C. The second early response is the increased phosphorylation of several proteins on tyrosine residues by PTK. This includes the phosphorylation of the CD-{ chain, a postulated critical early event (1 1, 12). The third response is the major increase in (Ca2+)i due to transmembrane uptake of Ca2+ through ligand-gated Ca2+ channels (1 3). These three responses have been linked: inhibition of tyrosine phosphorylation abolishes changes in inositol phosphate metabolism and Ca2+ mobilization. However, the exact sequence and regulation of the critical events remains to be defined as discussed below. Gating or opening of these channels is regulated at several different levels including the state of membrane potential at the time of TCR engagement (14), the level of (Ca2+), (13), and possibly by InsP3 or a phosphorylated derivative, InsP4 (1 5). The role of PTK in T-cell activation has been implicated in studies using inhibitors such as genistein or herbimycin that block Ca2+ responses and InsP3 generation (16). T cells contain at least three members of the src family of nonreceptor PTK genes: lck, fin, and yes (17, 18) . The p56Ick kinase and an isoform of ~5 9 '~" '~' are found almost exclusively in T lymphocytes (18, 19) . Crosslinking of CD4 or CD8 activates Ick (20, 21) and is associated with phosphorylation of the CD3-< chain (21). p59/Y" interacts with the CD3 subunits (22), likely serving as a primary signal transduction element of the CD3/TCR complex. Both lck and fyn have been implicated in tyrosine phosphorylation of the < chain. The relationship between tyrosine phosphorylation of the { chain and TCR function is not clear (22) . In the absence of the { chain, there is incomplete assembly of CD3/TCR complex (23). Tyrosine phosphorylation of the { chain may be required for IL-2 production in response to antigen (24).
At least part of the control of < chain phosphorylation may reside in the phosphatase activity of CD45. This surface glycoprotein with tyrosine phosphatase activity appears to be essential for CD3/TCR-associated increases in (Ca2+)i (25).
After TCR stimulation, PLC is phosphorylated and activated (1 I, 26-28). Several studies have linked the phosphorylation of PLC with PTK causing phosphorylation of other proteins, e.g.
p5qYn. Attempts to show that PLC activation is regulated by a G protein coupled to the CD3/TCR have been inconclusive (29) .
Assimilating all these data into a scheme for T-cell activation indicates that induction of IL-2 synthesis requires the activation of CD45 phosphatase, the activation of at least one PTK, i.e. p5qYn, the phosphorylation of the CD3-{ chain on tyrosine residues, and the opening of the plasma membrane, ligand-gated Ca2+ channel. The failure to I) form an intact CD3/TCR complex, 2) express these phosphatase or kinase activities, or 3) trigger Ca2+ influx is associated with a failure to trigger IL-2 gene transcription. The role of p56'ck in this cascade is unclear at present, although absence of this kinase is associated with a marked arrest of T-cell development at an early stage of ontogeny and T-cell lymphopenia (30). These conclusions are based on in vitro experiments with mutant cell lines or recent investigations using transgenic mice.
A defect localized to an impaired association of the CD3-{ chain with other chains of the CD3/TCR complex has been described in a Spanish family (31). This resulted in impaired surface expression of the CD3/TCR complex. Surprisingly, both mild and severe clinical presentations were noted, perhaps correlating with levels of TCR surface expression. Most T-cell immune deficiencies are characterized by normal Ca2+ influx but are associated with a failure to initiate IL-2 gene transcription. There have been some notable exceptions, but the pathogenesis of the abnormalities is unclear (32, unpublished observations).
These early activation events somehow link surface receptormediated phenomena to the nuclear induction of several critical activation genes. Transcriptional regulation accounts for most of the regulation of T-cell activation genes. A variety of nuclear or enhancer proteins interacting with specific regulatory sequences within these gene segments play a major role as targets for signals after antigen-receptor ligation. The important enhancer protein for IL-2 (and perhaps IL-4) is located in the 5' flanking sequences of the IL-2 gene and has been identified as NF-AT (7). Activation of NF-AT appears dependent on Ca2+ mobilization, presumably Ca2+ influx. The influx of Ca2+ is perhaps most critical for the nuclear shuttling of a constitutively expressed cytoplasmic component of NF-AT (33). Together with an inducible nuclear component of NF-AT, the complex positively regulates IL-2 gene activation (33). The immunosuppressants cyclosponn A and FK506 interfere with this shuttling, preventing IL-2 gene activation. The mechanism of inhibition is not clear but may be related to the effect of these drugs on the important calciumcalmodulin-dependent phosphatase, calcineurin (34). Although not exclusively expressed in T cells, the relative restriction of NF-AT to T cells makes it a possible candidate for T-cell immunodeficiency. Indeed, a patient with severe combined immunodeficiency and phenotypically normal T cells but deficient mRNA coding for IL-2, IL-3, IL-4, and IL-5 has been linked to an abnormal NF-AT nuclear transcription complex (35, 35a).
IL-DEPENDENT CELL PROLIFERATION
Whereas the signaling requirements for IL secretion are relatively stringent, the expression of functional high-affinity receptors, including IL-2R, are less so. It is unclear what are the essential activation signals required for IL-receptor expression. In the case of the IL-2R, Ca2+ mobilization does not appear essential (8). Specific defects in IL-receptor expression have not yet been described except for the possibility of IL-1R (36).
Because IL-2 functions as a progression signal, ligation of the receptor activates a number of pathways and substrates. Activation of the IL-2R does not result in Ca2+ mobilization or phosphatidylinositol hydrolysis (37, 38). IL-2 increases tyrosine phosphorylation of a number of intracellular proteins and the phosphorylation of several kinases including MAP-2 kinase and S6 kinase (38-41). The role of p56'ck in IL-2-dependent signaling may be important as this kinase is activated after IL-2 binding to its receptor (42, 43). Because some IL-2-responsive cell lines s 18 GELF 'AND lack p56lCk, it may not be essential for IL-2-dependent signaling (38) . None of these pathways appears unique to T cells, so any possible defect presumably would affect many different cell types. Because the immunosuppressant rapamycin is a potent inhibitor of IL-2-mediated cell proliferation (44), definition of its point of action may reveal some unique signaling pathway.
SUMMARY
The multiplicity of signaling pathways activated by ligation of TCR complexes is slowly being unraveled. They provide many targets for disruption with the potential for a T-cell immunodeficiency state to emerge. On the other hand, few of these pathways are restricted solely to T cells. Moreover, there is a certain redundancy in these pathways, which provides little opportunity for one component to be absolutely essential. Nevertheless, careful evaluation of these processes will likely lead to the definition of new disorders and, hopefully, innovative therapies. Dr. Pahwa: You mentioned that IL-2 receptor expression is independent of calcium mobilization. Is that true for mRNA for both IL-2 receptor and surface IL-2 receptor expression? As you know, there is some evidence that posttranscriptional regulation of IL-2-receptor expression might be calcium dependent.
Dr. Gelfand: The big change is in p55 message and protein
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expression since p75 is constitutively on, so you do not need a change in the levels of free cytosolic calcium. Remember, this does not mean that it is not calcium dependent in terms of what is already within the cytosol. I am just talking about the need for calcium mobilization to detect a change from baseline levels. Dr. Sorenson: What kind of stimuli activate the IL-4-driven proliferation? Have you identified some kind of antigen that would interact with the a//3 chains and trigger this kind of proliferation?
Dr. Gelfand: In terms of IL-4 itself driving the IL-4 receptor and causing the cells to proliferate, there is no evidence now for tyrosine phosphorylation, calcium influx, or IP (inositol phosphate) metabolism. Whether other phosphoglycans are involved is unclear at the present time. In terms of driving it specifically, even in a calcium-independent fashion, the best recognized form is using a combination of anti-CD28 antibody with a phorbol ester. That will certainly drive the IL-4 system, in fact even more than IL-2 in our hands, and that again is in the absence of calcium.
Dr. Levinson: Dr. Gelfand, let me throw out a naive possibility to explain the dissociation that you saw in the patient whose double-positive thymocytes proliferated, and you saw only CD4 cells out in the periphery. Is it possible that you are getting a calcium boost in a double-positive population of cells that otherwise would be differentiating toward CD8? You get that signal, and those cells are induced to undergo apoptosis; whereas the cells that are going to differentiate along the CD4 pathway do not get that initial calcium signal so that they don't undergo programmed cell death. The latter cells may get out into the periphery, but because they are lacking some pathway that is involved in that calcium signal they cannot proliferate once they get out there. Dr. Gelfand: In fact, that is one of the hypotheses that we have developed, that it is a leak-through, that it bypasses the apoptotic mechanism. That is why I asked Dr. Perlmutter about the role of p59, because one could also speculate that the cells may be overexpressing p59 at a double-positive stage and escaping the apoptotic mechanism only in one lineage, not in CD8 but in the CD4 population. On seeing Dr. Perlmutter's data, one wonders about the overexpression of p59 in these patients. The knockout experiments that he talked about, which Tak Mak has done, and also the types of experiments that Dr. Perlmutter has done have led to a deficiency of both CD4 and CD8 in the periphery, at least in the mouse. That is where there is a bit of a discrepancy.
Dr. Strober: Is it possible that in some of these situations the mechanism of cell activation and calcium influx is, in a sense, decoupled from the mechanisms that are necessary for activating lymphokine genes and lymphokine receptor genes? Could it be that we would find normal calcium influx and normal phospholipid turnover and so on, but we are not looking in the right place in terms of what is really necessary for generation of the nuclear binding factors required for the gene activation events?
Dr. Gelfand: Yes, it is possible. I think this is an important question because the overwhelming majority of the patients who have had abnormal proliferative responses or abnormal IL synthesis, even the SCIDs (patients with severe combined immunodeficiency disease) who have very few T cells, flux calcium perfectly normally. So the inability to flux calcium in T cells of these immunodeficient patients is actually rare. That leads to the question: Is calcium absolutely necessary or is that a bit of a red herring? Perhaps the cells that are present, despite their ability to flux calcium, do not have the subsequent mechanisms that are required for the transcriptional regulation of these important lymphokines.
